Clinical and Experimental Allergy

Article	Citations
Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID‐19 vaccine	184
Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19	118
Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases	89
The use of biologics in food allergy	60
Clinical manifestations and impact on daily life of allergy to polyethylene glycol (PEG) in ten patients	59
Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): A randomized double‐blind placebo‐controlled trial	54
Real‐world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: A systematic review and meta‐analysis	54
The epidemiology of eczema in children and adults in England: A population‐based study using primary care data	54
Mechanisms of oral immunotherapy	48
Paediatric and adolescent asthma: A narrative review of telemedicine and emerging technologies for the post‐COVID‐19 era	43
Digital health interventions in children with asthma	42
Skincare interventions in infants for preventing eczema and food allergy: A cochrane systematic review and individual participant data meta‐analysis	41
BSACI 2021 guideline for the management of egg allergy	40
Treating severe asthma: Targeting the IL‐5 pathway	37
BSACIguideline for the set‐up of penicillin allergy de‐labelling services by non‐allergists working in a hospital setting	36
Overlap of allergic, eosinophilic and type 2 inflammatory subtypes in moderate‐to‐severe asthma	36
Frequency of guideline‐defined cow's milk allergy symptoms in infants: Secondary analysis of EAT trial data	34
Treatment effectiveness for Vocal Cord Dysfunction in adults and adolescents: A systematic review	33
Adverse reactions to COVID‐19 vaccines: A practical approach	33
Trends in eczema prevalence in children and adolescents: A Global Asthma Network Phase I Study	32
Mast cell activation tests by flow cytometry: A new diagnostic asset?	31
Clinical evaluation of type 2 disease status in a real‐world population of difficult to manage asthma using historic electronic healthcare records of blood eosinophil counts	29
BSACIguideline for the diagnosis and management of pollen food syndrome in theUK	28
Revisiting Asian chronic rhinosinusitis in the era of type 2 biologics	28
The Polysorbate containing AstraZeneca COVID‐19 vaccine is tolerated by polyethylene glycol (PEG) allergic patients	28

Switching between biologics in severe asthma patients. When the first choice is not proven to be the best	27
Trends in use of specialized formula for managing cow's milk allergy in young children	25
Allergen labelling: Current practice and improvement from a communication perspective	24
Fungal sensitization and positive fungal culture from sputum in children with asthma are associated with reduced lung function and acute asthma attacks respectively	24
Real‐world Omalizumab and Mepolizumab treated difficult asthma phenotypes and their clinical outcomes	24
Role of autophagy in regulating interleukin‐10 and the responses to corticosteroids and statins in asthma	23
Repetitive nasal allergen challenge in allergic rhinitis: Priming and Th2‐type inflammation but no evidence of remodelling	23
Poor understanding of allergen labelling by allergic and non‐allergic consumers	22
Sputum microRNA‐screening reveals Prostaglandin EP3 receptor as selective target in allergen‐specific immunotherapy	22
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub‐phenotypes of response identified by cluster analysis	22
Eosinophilic esophagitis: Immune mechanisms and therapeutic targets	22
Neutrophilic asthma features increased airway classical monocytes	22
High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients	21
Information needs of patients considering oral immunotherapy for food allergy	21
Fruit, vegetable and dietary antioxidant intake in school age, respiratory health up to young adulthood	21
A polygenic risk score for asthma in a large racially diverse population	20
Investigating the causal relationship between allergic disease and mental health	20
The evolving landscape of biologic therapies for atopic dermatitis: Present and future perspective	20
Sex‐specific associations of asthma acquisition with changes in DNA methylation during adolescence	19
MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: Modulation by sugammadex	19
Patterns and trends in eczema management in UK primary care (2009–2018): A population‐based cohort study	19
Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response	19
Lipid transfer protein allergy: A review of current controversies	19
The effects of increasing fruit and vegetable intake in children with asthma: A randomized controlled trial	19
A qualitative and quantitative comparison of IgE antibody profiles with two multiplex platforms for component‐resolved diagnostics in allergic patients	18
Micronutritional supplementation with a holoBLG‐based FSMP (food for special medical purposes)‐lozenge alleviates allergic symptoms in BALB/c mice: Imitating the protective farm effect	18
Decrease in CD38+ TH2A cell frequencies following immunotherapy with house dust mite tablet correlates with humoral responses	18
National Survey of United Kingdom Paediatric Allergy Services	18
Human β‐defensin‐2 suppresses key features of asthma in murine models of allergic airways disease	18
Cyclophilin – A novel cross‐reactive determinant in peanut	17
The effect of water hardness on atopic eczema, skin barrier function: A systematic review, meta‐analysis	17
Sensitization to peanut, egg or pets is associated with skin barrier dysfunction in children with atopic dermatitis	17
Regulation of oral antigen delivery early in life: Implications for oral tolerance and food allergy	17
@IT2020: An innovative algorithm for allergen immunotherapy prescription in seasonal allergic rhinitis	17
WITHDRAWN: Glucocorticoids ameliorate periostin‐induced tissue remodeling in chronic rhinosinusitis with nasal polyps	17
Transcriptomics of biopsies identifies novel genes and pathways linked to neutrophilic inflammation in severe asthma	16
Outdoor pollen‐related changes in lung function and markers of airway inflammation: A systematic review and meta‐analysis	16
Advanced glycation end product intake during pregnancy and offspring allergy outcomes: A Prospective cohort study	16
Effect of Acinetobacter lwoffii on the modulation of macrophage activation and asthmatic inflammation	16
Assessment of adherence to corticosteroids in asthma by drug monitoring or fractional exhaled nitric oxide: A literature review	16
Population prevalence of allergic bronchopulmonary aspergillosis in asthma: An epidemiological study of 43,261 participants from North India	16
Peptide allergen‐specific immunotherapy for allergic airway diseases—State of the art	16
Pharmacokinetics of adrenaline autoinjectors	16
A virtual management approach to infant egg allergy developed in response to pandemic‐imposed restrictions	15
The impact of prenatal dog keeping on infant gut microbiota development	15
Clonal mast cell disorders and hereditary α‐tryptasemia as risk factors for anaphylaxis	15
Tryptase release does not discriminate between IgE‐ and MRGPRX2‐mediated activation in human mast cells	15
Hypotheses to explain the associations between asthma and the consequences of COVID‐19 infection	15
The Asian wasp Vespa velutina nigrithorax: Entomological and allergological characteristics	15
INEXAS: A Phase 2 Randomized Trial of On‐demand Inhaled Interferon Beta‐1a in Severe Asthmatics	14

Allergenicity at component level of sub‐pollen particles from different sources obtained by osmolar shock: A molecular approach to thunderstorm‐related asthma outbreaks	14
Allergic diseases in India – Prevalence, risk factors and current challenges	14
Evidence for causal associations between prenatal and postnatal antibiotic exposure and asthma in children, England	14
Exogenous factors in the pathogenesis of atopic dermatitis: Irritants and cutaneous infections	14
Type 2 immunity‐driven diseases: Towards a multidisciplinary approach	14
Clinical and immunological data from chronic urticaria onset after mRNA SARS‐CoV‐2 vaccines	13
Burden of allergic disease among ethnic minority groups in high‐income countries	13
Atopic dermatitis trajectories to age 8 years in the GUSTO cohort	13
Airway gene expression identifies subtypes of type 2 inflammation in severe asthma	13
Practical management of suspected hypersensitivity reactions to anti‐tuberculosis drugs	13
Diagnostic performance of serial serum total tryptase measurement to differentiate positive from negative allergy testing among patients with suspected perioperative hypersensitivity	13
Randomized controlled pilot trial with ion‐exchange water softeners to prevent eczema (SOFTER trial)	13
Mepolizumab decreases tissue eosinophils while increasing type‐2 cytokines in eosinophilic chronic rhinosinusitis	13
Intralymphatic immunotherapy with one or two allergens renders similar clinical response in patients with allergic rhinitis due to birch and grass pollen	13
COVID‐19 as a trigger of acute attacks in people with hereditary angioedema	13
Efficacy of inhaled salbutamol with and without prednisolone for first acute rhinovirus‐induced wheezing episode	13
Ocular surface disease is common in moderate‐to‐severe atopic dermatitis patients	13
Early‐life predictors and risk factors of peanut allergy, and its association with asthma in later‐life: Population‐based birth cohort study	13
Is antenatal or early‐life vitamin D associated with eczema or food allergy in childhood? A systematic review	13
An algorithm for safe de‐labelling of antibiotic allergy in adult hospital in‐patients	13
Automatic market research of mobile health apps for the self‐management of allergic rhinitis	13
Second‐hand smoke and NFE2L2 genotype interaction increases paediatric asthma risk and severity	13
Detection and management of milk allergy: Delphi consensus study	12
Mast cell activation test: A new asset in the investigation of the chlorhexidine cross‐sensitization profile	12
Characterization of anaphylaxis reveals different metabolic changes depending on severity and triggers	12
Hypersensitivity may be involved in severe COVID‐19	12
Immunotherapy with Vespula venom for Vespa velutina nigrithorax anaphylaxis: Preliminary clinical and immunological results	12
Protein and carbohydrate content of infant formula purchased in the United States	12
ImmunoCAP ISAC in food allergy diagnosis: a systematic review of diagnostic test accuracy	12
Simplified AIT for allergy to several tree pollens—Arguments from the immune outcome analyses following treatment with SQ tree SLIT‐tablet	11
Prevalence and early‐life risk factors for tree nut sensitization and allergy in young adults	11
Palforzia for peanut allergy: Panacea or predicament	11
Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study	11
Peanuts in the air ‐ clinical and experimental studies	11
Asthma did not increase in‐hospital COVID‐19‐related mortality in a tertiary UK hospital	11
Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on‐demand treatment of hereditary angioedema	11
Allergenic characterization of Bomb m 4, a 30‐kDa Bombyx mori lipoprotein 6 from silkworm pupa	11
Increased IL‐6 and Potential IL‐6 trans‐signalling in the airways after an allergen challenge	11
Identifying key priorities for research to protect the consumer with food hypersensitivity: A UK Food Standards Agency Priority Setting Exercise	11
'Diagnosing food protein‐induced enterocolitis syndrome'	11
Establishing subclasses of childhood eczema, their risk factors and prognosis	10
Substance P‐induced lung inflammation in mice is mast cell dependent	10
The impact of childhood asthma on academic performance: A matched population‐based cohort study	10
Airway Elastin is increased in severe asthma and relates to proximal wall area: histological and computed tomography findings from the U‐BIOPRED severe asthma study	10
Oral immunotherapy using boiled peanuts for treating peanut allergy: An open‐label, single‐arm trial	10
IgE‐mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to mRNA COVID‐19 vaccines	10
Health‐related quality of life in food and venom induced anaphylaxis and role of influencing factors	10
Allergy societies and the formula industry	10
Allergic bronchopulmonary aspergillosis in India	10
Nasal administration of a probiotic assemblage in allergic rhinitis: A randomised placebo‐controlled crossover trial	10
Pharmacogenetics of inhaled corticosteroids and exacerbation risk in adults with asthma	10
Inhibition of cow’s milk allergy development in mice by oral delivery of β‐lactoglobulin‐derived peptides loaded PLGA nanoparticles is associated with systemic whey‐specific immune silencing	10
Biomarkers for predicting response to aspirin therapy in aspirin‐exacerbated respiratory disease	10
Pharmacology, particle deposition and drug administration techniques of intranasal corticosteroids for treating allergic rhinitis	10
Epigenome alterations in food allergy: A systematic review of candidate gene and epigenome‐wide association studies	9
Allergen extract‐ and component‐based diagnostics in children of the ALLIANCE asthma cohort	9
Paediatric asthma and non‐allergic comorbidities: A review of current risk and proposed mechanisms	9
Management of IgE‐mediated food allergy in the 21st century	9
Allergic disease prevalence in school children in Bengaluru, India: A cross‐sectional survey	9
Altered immune cell profiles and impaired CD4 T‐cell activation in single and multi‐food allergic adolescents	9
Airway autoimmunity, asthma exacerbations, and response to biologics	9
Effects of dupilumab treatment on patch test reactions: A retrospective evaluation	9
Epigenetic methylation in Eosinophilic Esophagitis: Molecular ageing and novel biomarkers for treatment response	9
Heterogeneity of the pharmacologic treatment of allergic rhinitis in Europe based on MIDAS and OTCims platforms	9
Diagnostic accuracy of Ara h 2 for detecting peanut allergy in children	9
Blood eosinophils associate with reduced lung function growth in adolescent asthmatics	9
Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trial	9
Test‐guided dietary management of eczema in children: A randomized controlled feasibility trial (TEST)	9
Microbiome and mycobiome interaction in house dust mites and impact on airway cells	9
Childhood asthma: Novel endotyping by cytokines, validated through sensitization profiles and clinical characteristics	9
Validation study of a new chemiluminescent singleplex IgE assay in a set of Italian allergic rhinitis patients	9
Increased epithelial galectin‐13 expression associates with eosinophilic airway inflammation in asthma	9
Loss of smell in patients with aspirin‐exacerbated respiratory disease impacts mental health and quality of life	9
Children with acute food protein‐induced enterocolitis syndrome from Spain and Italy usually tolerate all other food groups	8
Basophil activation test for Staphylococcus aureus enterotoxins in severe asthmatic patients	8
Influence of climate change on airborne pollen concentrations in Madrid, 1979–2018	8
Parental socioeconomic status and asthma in children: Using a population‐based cohort and family design	8
A novel gain‐of‐function mutation in STAT5B is associated with treatment‐resistant severe atopic dermatitis	8
A cost‐analysis of outpatient paediatric penicillin allergy de‐labelling using telemedicine	8
Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease: Preliminary case series	8

Vancomycin immediate skin responses in vancomycin‐naïve subjects	8
Bacterial lysate add‐on therapy to reduce exacerbations in severe asthma: A double‐blind placebo‐controlled trial	8
Milk allergy guidelines for infants in England promote over‐diagnosis: A cross‐sectional survey	8
Sex‐specific developmental trajectories of eczema from infancy to age 26 years: A birth cohort study	8
Impact of COVID‐19 pandemic on quality of life for children and adolescents with food allergy	8
Bos d 11 in baked milk poses a risk for adverse reactions in milk‐allergic patients	8
Feasibility of an online CBT group intervention for parents of children with food allergy	8
Leukocyte redistribution as immunological biomarker of corticosteroid resistance in severe asthma	8
Fish collagen as a potential indicator of severe allergic reactions among patients with fish allergies	8
Bet v 1 triggers antiviral‐type immune signalling in birch‐pollen‐allergic individuals	8
Rectal bleeding and cow’s milk protein‐induced allergic proctocolitis: A prospective study	8
Hexamerin‐like protein 2, a cricket allergen involved in occupational and food allergy	8
Delayed reaction in alpha‐gal allergy is reflected in serum levels after ingestion of pork kidney, and absorption is dependent on food processing	8
ADRB2 haplotypes and asthma exacerbations in children and young adults: An individual participant data meta‐analysis	7
Delayed symptoms and orthostatic intolerance following peanut challenge	7
The Icatibant Outcome Survey: 10 years of experience with icatibant for patients with hereditary angioedema	7
Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis	7
Risk factors associated with rhinitis, allergic conjunctivitis and eczema among schoolchildren in Uganda	7
Oscillometry bronchodilator response in adult moderate to severe eosinophilic asthma patients: A prospective cohort study	7
Strain matters in mouse models of peanut‐allergic anaphylaxis: Systemic IgE‐dependent and Ara h 2‐dominant sensitization in C3H mice	7
Reliability of the breathing pattern assessment tool for in‐person or remote assessment in people with asthma	7
Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy	7
Asia Pacific perspectives on the second year of the COVID‐19 pandemic: A follow‐up survey	7
Growth pattern during early infancy, body mass index during childhood and childhood asthma	7
From trained immunity in allergy to trained immunity‐based allergen vaccines	7
Clinical examination for hyperlinear palms to determine filaggrin genotype: A diagnostic test accuracy study	7
Trajectories of early‐onset rhinitis in the Singapore GUSTO mother‐offspring cohort	7
Microbiota associations with inflammatory pathways in asthma	7
Limosilactobacillus reuteri DSM‐17938 for preventing cough in adults with mild allergic asthma: A double‐blind randomized placebo‐controlled cross‐over study	7
Allergic rhinitis in India	7
Histone deacetylase activity is a novel target for epithelial barrier defects in patients with eosinophilic chronic rhinosinusitis with nasal polyps	7
The role of epigenetics in multi‐generational transmission of asthma: An NIAID workshop report‐based narrative review	7
Environmental exposure of Der p 23 in household dust samples	7
As‐needed anti‐inflammatory reliever therapy for asthma management: evidence and practical considerations	7
Landscape of short‐acting beta‐agonists (SABA) overuse in Europe	7
Probiotic peanut oral immunotherapy is associated with long‐term persistence of 8‐week sustained unresponsiveness and long‐lasting quality‐of‐life improvement	7
Cannabinoid WIN55212‐2 impairs peanut‐allergic sensitization and promotes the generation of allergen‐specific regulatory T cells	7
Clinical and immunological evaluation of cat‐allergic asthmatics living with or without a cat	6
Elicitors and phenotypes of adult patients with proven IgE‐mediated food allergy and non‐immune‐mediated food hypersensitivity to food additives	6
Effectiveness of FeNO‐guided treatment in adult asthma patients: A systematic review and meta‐analysis	6
Microbiota of the first‐pass meconium and subsequent atopic and allergic disorders in children	6
Exploring proteomic plasma biomarkers in eosinophilic and neutrophilic asthma	6
Natural moisturizing factor as a biomarker for filaggrin mutation status in a multi‐ethnic paediatric atopic dermatitis cohort	6
Newborn DNA methylation and asthma acquisition across adolescence and early adulthood	6
Atopic dermatitis or eczema? Consequences of ambiguity in disease name for biomedical literature mining	6
Prenatal antibiotic use, caesarean delivery and offspring's food protein‐induced enterocolitis syndrome: A National Birth Cohort (JECS)	6
Current and future treatments for peanut allergy	6
Timing of complementary feeding for early childhood allergy prevention: An overview of systematic reviews	6
Non‐biologic systemic treatments for atopic dermatitis: Current state of the art and future directions	6
A new vicilin‐like allergen in hazelnut giving rise to a spectrum of IgE‐binding low‐molecular‐weight N‐terminal fragments	6
House dust mite components sensitization profile in China, a multi‐centre study	6
National trends in asthma prevalence in South Korea before and during the COVID‐19 pandemic, 1998–2021	6
Effectiveness and safety of low‐dose oral immunotherapy protocols in paediatric milk and egg allergy	6
Biologics in severe asthma: Which one, When and Where?	6
Biologic therapy practices in severe asthma; outcomes from the UK Severe Asthma Registry and survey of specialist opinion	6
COVID‐19 vaccines and anaphylaxis—evaluation with skin prick testing, basophil activation test and Immunoglobulin E	6
Selective inhibition of prostaglandin D2 biosynthesis in human mast cells to overcome need for multiple receptor antagonists: Biochemical consequences	6
The causes of a peripheral blood eosinophilia in a secondary care setting	6